Genetic studies have shown that the overall risk of AD is primarily associated with gene expression in glial cells, with clusterin/apolipoprotein J (CLU/ApoJ), sortilin-related receptor (SORL1), and the fermitin family member 2 (FERMT2) as the main genes involved. The gene discussed is CLU; the disease is Alzheimer disease.